Follow-up report on the diagnosis of diabetes mellitus.
- S. Genuth, K. Alberti, P. Zimmet
- MedicineDiabetes Care
- 1 November 2003
The International Expert Committee was convened to reexamine the classification and diagnostic criteria of diabetes, which were based on the 1979 publication of the National Diabetes Data Group and subsequent WHO study group and adopted several changes to the diagnostic criteria for diabetes and for lesser degrees of impaired glucose regulation (IFG/IGT).
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long‐Term Complications in Insulin‐Dependent Diabetes Mellitus
- D. Nathan, S. Genuth, C. Siebert
- MedicineNew England Journal of Medicine
- 29 September 1993
Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
Intensive diabetes therapy has long-term beneficial effects on the risk of cardiovascular disease in patients with type 1 diabetes, and changes between treatment groups remained significant after adjusting for these factors.
Effects of intensive glucose lowering in type 2 diabetes.
- H. Gerstein, Michael E. Miller, W. Friedewald
- MedicineNew England Journal of Medicine
- 12 June 2008
The use of intensive therapy to target normal glycated hemoglobin levels for 3.5 years increased mortality and did not significantly reduce major cardiovascular events and identify a previously unrecognized harm of intensive glucose lowering in high-risk patients with type 2 diabetes.
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Overall, there was no significant difference in the rates of death and major cardiovascular events between patients undergoing prompt revascularization and those undergoing medical therapy or between strategies of insulin sensitization and insulin provision.
Effects of medical therapies on retinopathy progression in type 2 diabetes.
- E. Chew, W. Ambrosius, Lawrence J. Fine
- MedicineNew England Journal of Medicine
- 15 July 2010
Intensive glycemic control and intensive combination treatment of dyslipidemia, but not intensive blood-pressure control, reduced the rate of progression of diabetic retinopathy.
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
- F. Ismail-Beigi, T. Craven, I. Hramiak
- MedicineThe Lancet
- 7 August 2010
Report of the expert committee on the diagnosis and classification of diabetes mellitus.
- J. Gavin, K. Alberti, M. Stern
- MedicineDiabetes Care
- 14 January 1999
It was deemed essential to develop an appropriate, uniform terminology and a functional, working classification of diabetes that reflects the current knowledge about the disease.
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
- H. Gerstein, Michael E. Miller, W. Friedewald
- MedicineNew England Journal of Medicine
- 3 March 2011
The use of intensive therapy for 3.7 years to target a glycated hemoglobin level below 6% reduced 5-year nonfatal myocardial infarctions but increased 5- year mortality, and such a strategy cannot be recommended for high-risk patients with advanced type 2 diabetes.
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
Members of the International Expert Committee have recommended that diabetes should be diagnosed if A1C is ≤6.5%, without need to measure the plasma glucose concentration (1). We are concerned that…
...
...